Thread regarding Emergent Biosolutions Inc. layoffs

Specialty biopharmaceutical company

Emergent BioSolutions is a specialty biopharmaceutical company headquartered in Gaithersburg, Maryland, USA. It develops vaccines and antibody therapeutics for infectious diseases, o—id overdoses, and provides medical devices for biodefense purposes.

Stock price: EBS (NYSE) $44.91 +0.42 (+0.94%)

  • Headquarters: Rockville, MD
  • Revenue: 782.4 million USD (2018)
  • Subsidiaries: PaxVax, Cangene, ADAPT Pharma Inc., CBL/GP Inc, MORE
  • Key people: Robert G. Kramer Sr., Fuad El-Hibri
| 839 views | | no replies yet
Post ID: @OP+10qDySkH

There are no replies in this thread yet. Be the first to post a reply below:

Post a reply